• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
张百刚,杨善德,李燕,等. 文成糯山药多糖纯化与体外生物活性研究J. 食品工业科技,2025,46(19):113−121. doi: 10.13386/j.issn1002-0306.2024100153.
引用本文: 张百刚,杨善德,李燕,等. 文成糯山药多糖纯化与体外生物活性研究J. 食品工业科技,2025,46(19):113−121. doi: 10.13386/j.issn1002-0306.2024100153.
ZHANG Baigang, YANG Shande, LI Yan, et al. Purification and in Vitro Bioactivity of Polysaccharide from Wencheng Waxy YamJ. Science and Technology of Food Industry, 2025, 46(19): 113−121. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024100153.
Citation: ZHANG Baigang, YANG Shande, LI Yan, et al. Purification and in Vitro Bioactivity of Polysaccharide from Wencheng Waxy YamJ. Science and Technology of Food Industry, 2025, 46(19): 113−121. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024100153.

文成糯山药多糖纯化与体外生物活性研究

Purification and in Vitro Bioactivity of Polysaccharide from Wencheng Waxy Yam

  • 摘要: 目的:探究糯山药多糖调节糖脂代谢的潜力。方法:利用DEAE-52纤维素色谱纯化得到糯山药多糖(WCYP1),并评价其抗氧化、降血糖、降血脂活性及改善胰岛素抵抗(IR)能力。结果:WCYP1总糖含量为96.90%,蛋白质含量为2.78%;红外扫描具有多糖典型特征吸收峰;重均分子量为145.693 kDa、数均分子量为45.628 kDa;WCYP1由岩藻糖1.41%、鼠李糖5.89%、阿拉伯糖1.90%、半乳糖5.47%、葡萄糖13.49%、木糖2.79%、甘露糖67.89%、葡萄糖醛酸1.17%组成;WCYP1浓度为3 mg/mL时,对DPPH和ABTS+自由基清除率分别为79.41%±0.47%和81.14%±1.97%;对α-淀粉酶和α-葡萄糖苷酶抑制率分别为84.21%±5.26%和36.67%±1.15%。当WCYP1浓度达到4 mg/mL时,对牛磺胆酸钠、甘氨胆酸钠的结合率分别为98.07%±0.02%和98.03%±0.06%。200、500、800 µg/mL WCYP1均能显著提高IR-HepG2的葡萄糖消耗量(P<0.05),且与浓度呈正相关,200、500 µg/mL WCYP1给药24 h不影响IR-HepG2细胞活性。结论:WCYP1具有一定的体外抗氧化、降血糖、降血脂作用,能够有效改善IR状态,可为WCYP1的开发利用提供理论支持。

     

    Abstract: Objective: To explore the potential of waxy yam polysaccharide in regulating glycolipid metabolism. Methods: Waxy yam polysaccharide (WCYP1) was purified using DEAE-52 cellulose chromatography, and its antioxidant, hypoglycemic, hypolipidemic activities and ability to improve insulin resistance (IR) were evaluated. Results: The total sugar content of WCYP1 was determined to be 96.90%, while the protein content was 2.78%. Infrared scanning revealed typical characteristic absorption peaks of polysaccharides. The weight-average molecular weight of WCYP1 was determined to be 145.693 kDa, while the number-average molecular weight was 45.628 kDa. WCYP1 consisted of 1.41% fucose, 5.89% rhamnose, 1.90% arabinose, 5.47% galactose, 13.49% glucose, 2.79% xylose, 67.89% mannose, and 1.17% glucuronic acid. At a concentration of 3 mg/mL, the DPPH and ABTS+ free radicals scavenging rates were 79.41%±0.47% and 81.14%±1.97%; the inhibition rates on α-amylase and α-glucosidase were 84.21%±5.26% and 36.67%±1.15%. When the WCYP1 concentration reached 4 mg/mL, the binding rates to sodium taurocholate and sodium glycocholate were 98.07%±0.02% and 98.03%±0.06%. And 200, 500, 800 µg/mL WCYP1 could significantly increase the glucose consumption of IR-HepG2 (P<0.05), and there was a positive correlation with the concentration. Meanwhile, 200 and 500 µg/mL WCYP1 administration for 24 h didn't affect the viability of IR-HepG2 cells. Conclusion: WCYP1 had certain in vitro antioxidant, hypoglycemic and hypolipidemic effects, and could effectively improve the state of IR. This provided theoretical support for the development and utilization of WCYP1.

     

/

返回文章
返回